Beta Bionics, Inc. 8-K

What Happened
On January 8, 2026, Beta Bionics, Inc. announced preliminary, unaudited fourth quarter 2025 topline financial results and key operating metrics in a press release. The company filed the press release as Exhibit 99.1 to an 8-K under Item 2.02 (Results of Operations and Financial Condition). The report was signed by President and CEO Sean Saint.

Key Details

• Filing date: January 8, 2026 (Form 8-K, Item 2.02).
• Disclosure type: Preliminary, unaudited topline quarterly results and key metrics for Q4 2025.
• Press release attached as Exhibit 99.1 to the 8-K.
• Report executed by Sean Saint, President and CEO.

Why It Matters
This filing gives investors an early, company-provided view of Beta Bionics’ Q4 2025 performance (topline results and key metrics). Because the figures are described as preliminary and unaudited, they could be updated or revised in subsequent filings (e.g., quarterly report or audited statements). Retail investors should review the attached press release for the specific numbers and watch for the company’s upcoming SEC filings or investor communications for finalized results.